Skip to main content
Guhan Pharmaceutical Group Co., Ltd. logo

Guhan Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 000590 ISIN · CNE000000701 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,714 across all filing types
Latest filing 2017-06-08 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 000590

About Guhan Pharmaceutical Group Co., Ltd.

https://www.tuspharma.cn

Guhan Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and sale of traditional Chinese medicine (TCM) and health-related products. The company is widely recognized for its flagship product, Guhan Yangsheng Jing, which is formulated based on ancient health preservation prescriptions discovered in the Mawangdui Han Dynasty Tombs. Its product portfolio includes oral liquids, tablets, and capsules designed to enhance vitality, support kidney function, and promote overall longevity. The organization integrates classical medical theories with modern pharmaceutical manufacturing processes to ensure product efficacy and safety. Beyond its core TCM offerings, the group engages in the production of chemical drugs and health supplements, targeting markets seeking natural wellness solutions. The company emphasizes the preservation of cultural heritage through the modernization of ancient medical wisdom.

Recent filings

Filing Released Lang Actions
第八届董事会第一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the first meeting of the eighth board of directors of the company. It includes election of board chairman, vice chairman, appointment of board secretary and securities affairs representative, election of various board committees, appointment of senior management personnel, approval of remuneration schemes for senior management and supervisors, amendments to the company articles of association, and other governance matters. The document also includes biographies of the appointed directors and senior management. There is no financial data or financial statements presented, nor is it a transcript of a call or a presentation. The content is focused on board and senior management changes and governance decisions. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is sufficient and the content is substantive, not a mere announcement of a report publication or a regulatory filing. Hence, the classification is MANG with high confidence.
2017-06-08 Chinese
关于使用募集资金置换前期已投入自筹资金的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement by the company regarding the use of raised funds to replace previously invested self-raised funds. It includes details about the fundraising, approvals by the board, supervisory board, independent directors, and auditors' verification reports. The document is relatively short (3057 characters) and primarily serves as a disclosure or announcement of a financial transaction related to capital use. It does not contain comprehensive financial statements or detailed financial performance data. It is not a full annual or interim report, nor an earnings release. The content fits best with a Capital/Financing Update (CAP) as it discusses fundraising and the use of proceeds.
2017-06-08 Chinese
中德证券有限责任公司关于公司详式权益变动报告书之财务顾问核查意见
Major Shareholding Notification Classification · 95% confidence The document is a detailed financial advisor's verification opinion on a "详式权益变动报告书" (Detailed Equity Change Report) related to a significant equity change in a listed company, 启迪古汉集团股份有限公司. It references Chinese securities laws, regulations, and specific disclosure standards (e.g., 《公开发行证券的公司信息披露内容与格式准则第15号-权益变动报告书》 and 第16号-上市公司收购报告书). The document includes extensive due diligence, verification of the equity change, funding sources, legal compliance, and impact analysis on the listed company. It is not a general annual or interim report, nor an earnings release or management discussion. It is a formal report related to a significant shareholding change and equity acquisition, with financial advisor's audit and opinion on the equity change report. This fits the category of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds. The document is substantive and not a mere announcement or certification, so it is not RNS or RPA. Therefore, the correct classification is MRQ with high confidence.
2017-06-01 Chinese
详式权益变动报告书
Major Shareholding Notification Classification · 100% confidence The document is titled as a "详式权益变动报告书" which translates to a "Detailed Equity Change Report." It is issued by the information disclosure obligor (信息披露义务人) regarding an increase in shareholding in the listed company 启迪古汉集团股份有限公司. The content includes detailed information about the equity change, the parties involved, legal references to Chinese securities laws and regulations, and extensive disclosures about the shareholders, their backgrounds, and the nature of the shareholding change. This type of document is a formal report on changes in major shareholding stakes, consistent with notifications required when significant shareholders cross ownership thresholds or increase/decrease their holdings. It is not an annual report, earnings release, or management report. It is not a proxy statement or voting result announcement. It is not a regulatory filing of miscellaneous nature but a specific equity change report. Therefore, the document fits the category of "Major Shareholding Notification" (Code: MRQ). The document length (15,000 characters) and detailed content confirm it is the report itself, not just an announcement of a report publication or a certification letter.
2017-06-01 Chinese
关于签订募集资金三方监管协议的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the signing of a tripartite supervision agreement for raised funds related to a non-public stock issuance. It details the amount raised, the opening of special accounts for the funds, and the supervisory responsibilities of involved parties. The document references regulatory approvals and compliance with stock exchange rules but does not contain financial statements or substantive financial data. The length is under 5,000 characters and the content is focused on the announcement of the agreement and fund management procedures rather than a financial report or detailed financial results. Therefore, it fits best as a Capital/Financing Update (CAP) since it concerns fundraising activities and the management of raised capital.
2017-05-24 Chinese
关于控股股东增持公司股份计划的公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding the controlling shareholder's plan to increase their shareholding in the company. It details the shareholder's current holdings, the planned increase, the purpose, method, funding, and timeframe of the share purchase. There are no financial statements, earnings data, or regulatory filings of financial results. The document is a formal disclosure of a shareholding change plan by a major shareholder, which fits the definition of a Major Shareholding Notification (MRQ). The document length is short and focused solely on this notification, not a report or other type of filing.
2017-05-24 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.